Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Glycerin
Drug ID BADD_D01031
Description A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Indications and Usage It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
Marketing Status approved; investigational
ATC Code A06AX01; A06AG04
DrugBank ID DB09462
KEGG ID D00028
MeSH ID D005990
PubChem ID 753
TTD Drug ID Not Available
NDC Product Code 73017-3111; 82609-001; 34645-2105; 42126-6310; 51367-009; 55681-750; 57896-181; 68016-015; 70000-0429; 70000-0572; 70441-0005; 82145-0001; 24208-006; 46122-222; 49953-0925; 58980-409; 63868-283; 67172-502; 69196-1001; 70000-0450; 81810-304; 81810-305; 42126-6100; 42126-6400; 43749-440; 63868-282; 68788-7266; 69196-2002; 72701-106; 72972-002; 73024-429; 81810-301; 82160-641; 82385-103; 0132-0075; 69196-2001; 81810-302; 82145-0003; 51552-0094; 73031-001; 11822-3312; 37808-398; 42126-6200; 58980-410; 64117-233; 67777-161; 69842-722; 72701-105; 24765-105; 49873-401; 52316-724; 52316-725; 69842-724; 72972-005; 72988-0002; 82974-001; 63163-001; 0132-0190; 68016-161; 71080-0031; 72972-001; 72972-004; 51672-5309; 67777-233; 68786-160; 73024-399; 73490-0001; 73513-323; 81810-303; 82385-104; 51552-1026; 11822-3321; 0132-0081; 0132-0185; 37808-399; 42126-6500; 49967-586; 52316-720; 52316-723; 62032-614; 72113-104; 82305-006; 0132-0195; 46122-221
UNII PDC6A3C0OX
Synonyms Glycerol | 1,2,3-Propanetriol | Glycerine | 1,2,3-Trihydroxypropane | Glycerin
Chemical Information
Molecular Formula C3H8O3
CAS Registry Number 56-81-5
SMILES C(C(CO)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Bradycardia02.03.02.002--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Cough22.02.03.001--
Cyanosis23.06.04.005; 02.11.04.004; 24.03.01.007; 22.02.02.007--
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dyspnoea02.11.05.003; 22.02.01.004--
Erythema23.03.06.001--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Hypotension24.06.03.002--
Lacrimation increased06.08.02.004--
Local reaction08.01.03.012--Not Available
Loss of consciousness17.02.04.004--Not Available
Oedema peripheral08.01.07.007; 02.05.04.007; 14.05.06.011--
Pain08.01.08.004--
Pallor24.03.04.001; 23.03.03.031; 08.01.03.032--Not Available
Pruritus23.03.12.001--
Rhinitis22.07.03.006; 11.01.13.004--
Shock24.06.02.002--Not Available
Sneezing22.12.03.024--
Swelling08.01.03.015--Not Available
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Wheezing22.03.01.009--
The 1th Page    1    Total 1 Pages